Manuel Adolfo
Sánchez Martín

Currently, M. Sánchez-Martín is Assistant Professor at the Department of Medicine of the University of Salamanca and he is running the Transgenic facility since 2005. M. Sánchez-Martín finished his undergraduate studies in Biochemistry in 1994, beginning his predoctoral training focused on malignant blood diseases in 3 different centers: 1) At the Hematology Service of the Hospital Clínico Universitario of Salamanca, focused on molecular cytogenetic in leukemias. 2) At the Institute of Microbiology and Biochemistry, focused on modelling leukemia disease in mice. 3) At the Cancer Research Center, focused on studying SNAI2 role in neoplastic diseases arising from mesenchymal cells (leukemias, lymphomas and sarcomas). After this predoctoral training, he obtained the Ph Degree with "outstanding cum laude" qualification and the Extraordinary Award for his thesis work. As a result of his predoctoral training several scientific contributions were published in Q1 scientific journals. After that, he gained a postdoctoral fellowship by the Spanish Association for Cancer (AECC) and a postdoctoral research position as "Ramón y Cajal Spanish Research Program". He joined to the Department of Medicine at University of Salamanca as assistant professor in 2010. During his pre and postdoctoral career, he stayed at different scientific research centers such as INIA, CNB, INSTITUTO CAJAL and CNIO, focused on modelling human diseases in mouse. He also stayed in international centers such as Cold Spring Harbor (NY, US) focused on manipulating the mouse embryo and stem cells (4 weeks); and at Wellcome Trust Sanger Institute (Cambridge, UK) focused on “high throughput recombineering in ES cells” (24 weeks). He has participated as IP in two national and several regional research projects (national project ongoing). Linked to this research career, Dr. Sánchez Martín has carried out several teaching tasks, at the Pharmacy, Biotechnology or Medicine School. Currently, Dr. Sánchez-Martín, combines his teaching and research tasks with the direction of the Transgenesis Facility. He is an active member of Spanish society for the laboratory animal (SECAL) Spanis Society for Gen and Cellular Therapy (SETGyC) and of the International Society for Transgenic Technology (ISTT).